For a complete list of research studies, including those currently recruiting subjects, click here to visit the home page of each of the IOL's four Research Centers.
For a list of ongoing clinical trials in the area of psychiatry, click here.
Click here for Hartford Hospital trials listed on the clinicaltrials.gov website.
The research studies listed below are currently recruiting volunteers to participate.
 
For each study there is a brief description and contact information.

 


Bipolar Disorder in Pediatric and Adolescents (depressive episode)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment study in pediatric and adolescent depression associated with Bipolar I Disorder. All subjects who complete the 6-week study are eligible for a 104 week open-label flexible-dose trial of Lurasidone.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

Bipolar Disorder in Pediatric and Adolescents (manic episode)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a 4-week, double-blind, clinical trial using Ziprasidone treatment study in pediatric and adolescent mania associated with Bipolar I Disorder.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Depression in Adults

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a 12 month observational study for patients currently being treated with an approved antidepressant treatment.

For more information about this trial, please contact: 

Dr. John W. Goethe and Dr. Andrew Winokur
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Depression in Pediatric and Adolescents

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 7-17 years of age for a double-blind, clinical trial using Vilazodone for the treatment of pediatric and adolescent major depressive disorder. After completion of the 8-week study, subjects are eligible for a 6-month open-label trial of Vilazodone.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Schizophrenia in Adolescents (add-on medication)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 12-16 years of age for a 6-week, double-blind, clinical trial with, NaBen, as an add-on treatment study in pediatric and adolescent Schizophrenia.

For more information about this trial, please contact: 

Dr. John W. Goethe
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top


Sertraline Pediatric Registry (SPRITES)

This non-interventional study will examine the risks and benefits of up to 3 years of treatment with sertraline on cognition, emotional and physical development, and pubertal maturation in children ages 6 to 14 years. Recruitment Needs: Patients ages 6-14 diagnosed with an anxiety or depressive disorder that are starting sertraline or starting therapy but not taking sertraline, with an IOL psychiatrist or psychologist. This study will not alter treatment regimen.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top


Social Anxiety Disorder in Adults

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a 12-week double-blind study with a new study medication as a treatment for adults with symptoms of social anxiety or a diagnosis of social anxiety disorder.

For more information about this trial, please contact: 

Dr. John W. Goethe and Dr. Andrew Winokur
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Treatment-Resistant Depressive Disorder in Adults

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a 12-month double-blind and open-label study for the treatment major depressive disorder using an add-on medication with an anti-depressant treatment.

For more information about this trial, please contact: 

Dr. John W. Goethe and Dr. Andrew Winokur
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)